Global

UK health regulator approves GSK's vaccine for common respiratory virus RSV

Mon, 2023-07-10 09:44 — mike kraft

UK health regulator approves GSK's vaccine for common respiratory virus RSV Britain's health regulator approved GSK's vaccine for the respiratory syncytial virus (RSV), which causes thousands of hospitalisations and deaths annually, the drugmaker said on Monday. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about UK health regulator approves GSK's vaccine for common respiratory virus RSV
Log in or register to post comments

Research into the rare side effect 'Long Vax Syndrome

Mon, 2023-07-10 09:40 — mike kraft

What is known about the rare side effect 'Long Vax Syndrome'?

The phenomenon known as "Long Vax Syndrome" is gaining attention among researchers as they seek to better understand the potential side effects of the Covid-19 vaccine. Similar to the long-lasting symptoms experienced by some individuals with "Long Covid," Long Vax Syndrome is characterized by headaches, extreme fatigue, blood pressure issues, and abnormal heart rates that can persist for weeks or even longer. However, it is important to note that the number of reported cases of Long Vax Syndrome is significantly lower than the number of reported cases of Long Covid.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Research into the rare side effect 'Long Vax Syndrome
Log in or register to post comments

Heatwaves: 2013 expected to be world's hotest year, U.S. south to be hit this week

Mon, 2023-07-10 09:34 — mike kraft

Heatwaves: Why this summer has been so hot Experts are predicting that the developing El Niño is likely to make 2023 the world's hottest year. BBC News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Heatwaves: 2013 expected to be world's hotest year, U.S. south to be hit this week
Log in or register to post comments

Misinformation issue: Suggested ways to counter acceptance of misinformation

Fri, 2023-07-07 11:04 — mike kraft

There’s a Psychological ‘Vaccine’ against Misinformation A social psychologist found that showing people how manipulative techniques work can create resilience against misinformation Daisy Yuhas Scientific American

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Misinformation issue: Suggested ways to counter acceptance of misinformation
Log in or register to post comments

Record heat wave hits earth for third time this week

Fri, 2023-07-07 10:05 — mike kraft

For the third time this week, Earth sets an unofficial heat record Earth’s average temperature set a new unofficial record high on Thursday, the third such milestone in a week that already rated as the hottest on record.The planetary average hit 63 degrees Fahrenheit (17.23 degrees Celsius), surpassing the 62.9-degree mark (17.18 Celsius) set Tuesday and equaled We AP News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Record heat wave hits earth for third time this week
Log in or register to post comments

Tuberculosis on the rise for first time in decades after COVID-19

Fri, 2023-07-07 10:00 — mike kraft

Tuberculosis on the rise for first time in decades after COVID-19 interrupted public health interventions and increased inequality Tuberculosis is a dangerous bacterial infection of the lungs. Moyo Studio/E+ via Getty ImagesBefore SARS-CoV-2, the virus that causes COVID-19, spread across the world in 2020, tuberculosis was responsible for more deaths globally than any other infectious disease. But thanks to targeted public health efforts in the U.S. and globally, tuberculosis cases had been steadily falling for decades.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Tuberculosis on the rise for first time in decades after COVID-19
Log in or register to post comments

Robust pandemic preparedness strongly linked to lower COVID-19 mortality --international study

Thu, 2023-07-06 17:53 — mike kraft

New study shows robust pandemic preparedness strongly linked to lower COVID-19 mortality rates The vast majority of countries that entered the COVID-19 pandemic with strong capacity to prevent, detect, and respond to disease threats achieved lower pandemic mortality rates than less prepared nations, ... Science X

...

The researchers sought to understand how different countries performed during the COVID-19 pandemic and how that relates to their pandemic preparedness capacity as measured by the GHS Index. ...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Robust pandemic preparedness strongly linked to lower COVID-19 mortality --international study
Log in or register to post comments

Revive Therapeutics' experimental COVID treatment fails in late-stage study

Thu, 2023-07-06 10:06 — mike kraft

Revive Therapeutics' experimental COVID treatment fails in late-stage study Canada-based Revive Therapeutics said on Thursday its experimental COVID-19 treatment did not meet the main goal of a late-stage study. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Revive Therapeutics' experimental COVID treatment fails in late-stage study
Log in or register to post comments

RSV vaccine: Moderna seeks regulatory approval of RSV vaccine for people 60 and older

Thu, 2023-07-06 09:55 — mike kraft

Moderna seeks regulatory approval of RSV vaccine for people 60 and older - UPI.com Moderna has submitted its RSV vaccine for people 60 and older regulatory approval in the United States, European Union, Switzerland and Australia. UPI

...

Moderna said the regulatory applications come after positive data from a study of approximately 37,000 adults 60 or older in 22 countries. Its vaccine to protect from respiratory syncytial virus was found in these trials to be 83.7% effective as defined by two or more symptoms.

...

Country / Region Tags:

General Topic Tags: